ABBOTT LABORATORIES (ABT) Insider Transactions
Over the last 12 months, 24 ABBOTT LABORATORIES (ABT) insiders filed 84 SEC Form 4 transactions — $5.6M in open-market purchases ( 4 distinct buyers) and $1.4M in open-market sales. 0% of all transactions were executed under a pre-scheduled Rule 10b5-1 trading plan.
- $5.6MOpen-market buys (1y)
- $1.4MOpen-market sells (1y)
- 24Distinct insiders
- 84Transactions filed
- 0%Under Rule 10b5-1 plan
- 2026-04-28Latest filing
Recent Form 4 Filings Most recent 50 of 84 (1-year window)
Each row is a single Form 4 filing event for ABT, sourced directly from SEC EDGAR. The Type column classifies the SEC transaction code into Buy / Sell / Grant / Exercise / Other; the 10b5-1 badge marks trades executed under a pre-scheduled SEC Rule 10b5-1 plan.
| Date | Insider | Title | Type | SEC Code | Value | Shares | Price |
|---|---|---|---|---|---|---|---|
| 2026-04-28 | Moreland Mary K | EXECUTIVE VICE PRESIDENT | Buy | I | $501.7K | 5,314 | $94.41 |
| 2026-04-27 | STARKS DANIEL J | — | Buy | P | $926.5K | 10,000 | $92.65 |
| 2026-04-24 | Conroy Kevin T | — | Grant | A | $0 | 2,286 | $0.00 |
| 2026-04-24 | Stratton John G | — | Grant | A | $0 | 2,286 | $0.00 |
| 2026-04-24 | STARKS DANIEL J | — | Grant | A | $0 | 2,286 | $0.00 |
| 2026-04-24 | STARKS DANIEL J | — | Grant | A | $0 | 7,105 | $0.00 |
| 2026-04-24 | Roman Michael F | — | Grant | A | $0 | 2,286 | $0.00 |
| 2026-04-24 | O'Grady Michael | — | Grant | A | $0 | 2,286 | $0.00 |
| 2026-04-24 | O'Grady Michael | — | Grant | A | $0 | 5,929 | $0.00 |
| 2026-04-24 | McKinstry Nancy | — | Grant | A | $0 | 2,286 | $0.00 |
| 2026-04-24 | McKinstry Nancy | — | Grant | A | $0 | 2,305 | $0.00 |
| 2026-04-24 | McDew Darren W | — | Grant | A | $0 | 2,286 | $0.00 |
| 2026-04-24 | Kumbier Michelle | — | Grant | A | $0 | 2,286 | $0.00 |
| 2026-04-24 | Gonzalez Patricia Paola | — | Grant | A | $0 | 2,286 | $0.00 |
| 2026-04-24 | Blount Sally E. | — | Grant | A | $0 | 2,286 | $0.00 |
| 2026-04-24 | Babineaux-Fontenot Claire | — | Grant | A | $0 | 2,286 | $0.00 |
| 2026-04-24 | Ahuja Nita | — | Grant | A | $0 | 2,286 | $0.00 |
| 2026-04-23 | Boudreau Philip P | EVP AND CFO | Buy | I | $820.0K | 8,909 | $92.04 |
| 2026-04-23 | Boudreau Philip P | EVP AND CFO | Buy | P | $201.3K | 2,200 | $91.50 |
| 2026-03-31 | Stratton John G | — | Grant | A | $39.2K | 382 | $102.67 |
| 2026-03-31 | Roman Michael F | — | Grant | A | $37.7K | 367 | $102.67 |
| 2026-03-31 | Gonzalez Patricia Paola | — | Grant | A | $33.0K | 321 | $102.67 |
| 2026-03-31 | Alpern Robert J | — | Grant | A | $7.8K | 76 | $102.67 |
| 2026-03-31 | Ahuja Nita | — | Grant | A | $10.5K | 102 | $102.67 |
| 2026-03-23 | ORVILLE JACOB A | Senior Vice President | Grant | — | $0 | 13,255 | $0.00 |
| 2026-03-02 | Shroff Eric | Senior Vice President | Sell | — | $81.9K | 709 | $115.58 |
| 2026-03-02 | Salvadori Daniel Gesua Sive | EVP AND GROUP PRESIDENT | Sell | — | $102.3K | 885 | $115.58 |
| 2026-03-02 | Morrone Louis H. | EXECUTIVE VICE PRESIDENT | Sell | — | $132.2K | 1,144 | $115.58 |
| 2026-03-02 | Moreland Mary K | EXECUTIVE VICE PRESIDENT | Sell | — | $70.9K | 613 | $115.58 |
| 2026-03-02 | MCCOY JOHN A. JR. | VICE PRESIDENT AND CONTROLLER | Sell | — | $67.6K | 585 | $115.58 |
| 2026-03-02 | Cushman Elizabeth C. | EVP, GC AND SECRETARY | Sell | — | $30.4K | 263 | $115.58 |
| 2026-02-27 | Shroff Eric | Senior Vice President | Grant | — | $160.9K | 1,384 | $116.26 |
| 2026-02-27 | Scoggins Christopher J | EXECUTIVE VICE PRESIDENT | Grant | — | $581.0K | 4,997 | $116.26 |
| 2026-02-27 | Salvadori Daniel Gesua Sive | EVP AND GROUP PRESIDENT | Grant | — | $769.1K | 6,615 | $116.26 |
| 2026-02-27 | Morrone Louis H. | EXECUTIVE VICE PRESIDENT | Grant | — | $469.7K | 4,040 | $116.26 |
| 2026-02-27 | Moreland Mary K | EXECUTIVE VICE PRESIDENT | Grant | — | $538.3K | 4,630 | $116.26 |
| 2026-02-27 | MCCOY JOHN A. JR. | VICE PRESIDENT AND CONTROLLER | Grant | — | $132.8K | 1,142 | $116.26 |
| 2026-02-27 | Ford Robert B | CHAIRMAN AND CEO | Grant | — | $3.5M | 30,308 | $116.26 |
| 2026-02-27 | Earnhardt Lisa D | EVP AND GROUP PRESIDENT | Grant | — | $997.2K | 8,577 | $116.26 |
| 2026-02-27 | Cushman Elizabeth C. | EVP, GC AND SECRETARY | Grant | — | $165.2K | 1,421 | $116.26 |
| 2026-02-27 | Boudreau Philip P | EVP AND CFO | Grant | — | $865.1K | 7,441 | $116.26 |
| 2026-02-24 | Shroff Eric | Senior Vice President | Grant | — | $0 | 10,873 | $0.00 |
| 2026-02-24 | Shroff Eric | Senior Vice President | Grant | — | $0 | 44,821 | $0.00 |
| 2026-02-24 | Scoggins Christopher J | EXECUTIVE VICE PRESIDENT | Grant | — | $0 | 18,502 | $0.00 |
| 2026-02-24 | Scoggins Christopher J | EXECUTIVE VICE PRESIDENT | Grant | — | $0 | 76,273 | $0.00 |
| 2026-02-24 | Salvadori Daniel Gesua Sive | EVP AND GROUP PRESIDENT | Grant | — | $0 | 21,644 | $0.00 |
| 2026-02-24 | Salvadori Daniel Gesua Sive | EVP AND GROUP PRESIDENT | Grant | — | $0 | 89,226 | $0.00 |
| 2026-02-24 | Morrone Louis H. | EXECUTIVE VICE PRESIDENT | Grant | — | $0 | 15,418 | $0.00 |
| 2026-02-24 | Morrone Louis H. | EXECUTIVE VICE PRESIDENT | Grant | — | $0 | 63,561 | $0.00 |
| 2026-02-24 | Moreland Mary K | EXECUTIVE VICE PRESIDENT | Grant | — | $0 | 13,951 | $0.00 |
Showing the most recent 50 of 84 transactions. For the full 1-year history with sorting, filtering, and cross-ticker industry context, open the full insider transactions drilldown.
Top Insider Buyers of ABT By dollar volume, 1-year window
- Ford Robert B $2.0M
- STARKS DANIEL J $2.0M
- Boudreau Philip P $1.0M
- Moreland Mary K $501.7K
Methodology & FAQ
How We Track ABT Insider Transactions
Form 4 disclosures are sourced directly from SEC EDGAR and re-ingested on every pipeline cycle. A complete description of transaction-code handling, the open-market vs grant distinction, and the Rule 10b5-1 plan-reference heuristic is documented in the Methodology.
What is an SEC Form 4 filing for ABBOTT LABORATORIES?
Form 4 is a transaction-level disclosure that corporate insiders — officers, directors, and beneficial owners of more than 10% of a registered class of equity securities — must file with the SEC within two business days of any change in their beneficial ownership of ABBOTT LABORATORIES (ABT) shares.
What is a Rule 10b5-1 trading plan?
Rule 10b5-1 is an SEC rule that lets insiders schedule trades in advance under a written plan, providing an affirmative defense against insider-trading allegations as long as the plan was adopted in good faith and not while in possession of material non-public information. Form 4 rows marked "10b5-1" on this page indicate the underlying trade was executed under such a plan; rows without the badge are discretionary or did not reference a plan in the Form 4 footnotes.
How is "insider buying" different from a stock grant or option exercise?
An insider buy (SEC transaction code P) is an open-market purchase of ABBOTT LABORATORIES (ABT) stock executed at the prevailing market price using the insider's personal capital. Stock grants (code A) and option exercises (code M) are compensation events, not directional trades; they are tracked separately and excluded from the "conviction" signal because they are not discretionary purchases.
How recent is the data?
Form 4 transactions are typically reported within two business days of execution. Pactolio re-ingests the EDGAR feed on a nightly cycle and reflects new filings on the next ingest run, typically within 24 hours of EDGAR acceptance. The table on this page covers the most recent 1-year window.